Journal of Medicinal Chemistry p. 686 - 694 (1995)
Update date:2022-08-04
Topics:
Faull, Alan W.
Brewster, Andrew G.
Brown, George R.
Smithers, Michael J.
Jackson, Ruth
The design, synthesis, and pharmacology of a new class of compounds possessing bith thromboxane receptor antagonist and thromboxane synthase inhibitory properties are described.Replacement of the phenol group of the known thromboxane antagonist series 4(Z)-6-<(4RS,5SR)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl>hex-4-enoic acid by a 3-pyridyl group led to a series of compounds, 5, which were potent thromboxane synthase inhibitors and weak thromboxane antagonists.Further modifications at the dioxane C2 position led to compounds, 7, which were potent dual-acting agents.In the case of compound 7w, the dual activity was shown to reside almost exclusively in the (-)-enantiomer, 7x.Following oral dosing to rats and dogs, 7x (3 mg/kg) displayed significant dual activity over a period of at least 8 h.
View MoreCHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
website:https://www.yurisolar.com/en
Contact:+86-29-81101199
Address:No. 560, East Hangtian Road, Xi'an, China
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Shanghai Synmedia Chemical Co., Ltd
Contact:+86-21-38681880
Address:6th Floor, 11A Building, No.528 Ruiqing Road, Heqing town, Pudong new district, Shanghai China
Doi:10.1002/hlca.19930760709
(1993)Doi:10.1016/S0040-4039(00)60337-4
(1993)Doi:10.1007/BF00863826
(1992)Doi:10.1055/s-0033-1339690
(2013)Doi:10.1016/j.ejmech.2017.04.049
(2017)Doi:10.3390/molecules20046153
(2015)